The Maudsley Debate: a cause for hope

Dr James Davies writes: For the last 30 years those of us critical of the overprescribing and harms of psychiatric medications have been on the losing side, in the face of a powerful industry-backed medical model that has crowded out alternative voices and visions. The real importance of Wednesday’s Maudsley Debate is that it symbolised […]

Continue Reading 7

Broad press coverage for today’s Maudsley Debate and BMJ article on psychiatric drug harm

Several newspapers have included coverage of today’s Maudsley Debate and BMJ article which consider whether the long-term use of psychiatric drugs is causing more harm than good. The articles include: http://www.theguardian.com/society/2015/may/12/psychiatric-drugs-more-harm-than-good-expert http://www.telegraph.co.uk/news/nhs/11600868/Throw-away-the-antidepressants-urges-leading-scientist.html http://www.independent.ie/life/health-wellbeing/antidepressants-and-drugs-for-dementia-and-adhd-are-harmful-leading-professor-warns-31218279.html Professor Peter Gøtzsche is also mentioned in the lead article on the front page of The Daily Telegraph: http://www.telegraph.co.uk/news/health/news/11601032/NHS-tests-and-drugs-do-more-harm-than-good.html

Continue Reading 4

The third leading cause of death after heart disease and cancer? Experts debate the harmful effects of psychiatric medications

Following its launch last year and the subsequent criticism of its position by prominent psychiatrists in the The Times and The Lancet Psychiatry, the Council for Evidence-based Psychiatry (CEP) responded by issuing a challenge to its critics to engage in an open, public debate on psychiatric drug harm. Taking up this challenge, the Institute of Psychiatry at Kings College London […]

Continue Reading 6

Latest prescription data shows consumption of psychiatric drugs continues to soar

The latest prescription figures from the Health and Social Care Information Centre show that the UK is in the midst of a psychiatric drug epidemic.  Over 57m prescriptions for antidepressants were issued in England in 2014, enough for one for every man, woman and child.  This represents a 7.5% increase since 2013, and over 500% […]

Continue Reading 7

Allen Frances, editor of DSM-IV, developed Risperdal guidelines ‘in disregard of… conflict of interest’

Dr Paula Caplan, associate of the DuBois Research Institute at Harvard University, has written an article exposing historical ties between Dr Allen Frances, lead editor of DSM-IV, and Janssen Pharmaceuticals, a Johnson & Johnson subsidiary and the makers of Risperdal, a second generation antipsychotic. Caplan cites a 2010 court document written by Dr David J Rothman, a […]

Continue Reading 2

Maudsley Debate: long-term use of psychiatric drugs is causing more harm than good?

Following its launch last year and the subsequent criticism of its position by prominent psychiatrists in the The Times and The Lancet Psychiatry, CEP responded by issuing a challenge to its critics to engage in an open, public debate on psychiatric drug harm. CEP is therefore pleased to announce that Kings College London has agreed to host a […]

Continue Reading 16

Peter Gøtzsche’s latest book ‘Deadly Medicines and Organised Crime: How Big Pharma has Corrupted Healthcare’ wins first prize in BMA book awards 2014

Professor Peter Gøtzsche has won first prize in the 2014 BMA book awards in the Basis of Medicine Category with his most recent book, ‘Deadly Medicines and Organised Crime: How Big Pharma Has Corrupted Healthcare’, published by Radcliffe Publishing.  Peter is Director of the Nordic Cochrane Centre and a member of CEP. The BMA reviewer commented as […]

Continue Reading 4

Powered by WordPress. Designed by Woo Themes